Diagnosing A Condition With Cough, Fever, Night Sweats, Weight loss
Tuberculosis: Causes, Symptoms, Diagnosis, Treatment, and Prevention
Introduction
Tuberculosis (TB) is a chronic infectious disease caused primarily by Mycobacterium tuberculosis. Despite being preventable and treatable, it remains one of the leading causes of death from infectious diseases worldwide. TB mainly affects the lungs (pulmonary TB), but it can also involve other parts of the body such as bones, kidneys, lymph nodes, and the brain (extrapulmonary TB).
Causes and Transmission
TB is caused by the bacterium Mycobacterium tuberculosis. The infection spreads through airborne droplets released when an infected person coughs, sneezes, or speaks. A person may inhale these droplets and become infected. However, not everyone exposed to TB bacteria develops active disease.
- Latent TB infection (LTBI): The bacteria remain in the body but are inactive and cause no symptoms. The person is not contagious.
- Active TB disease: The bacteria multiply and cause illness, making the person infectious.
Risk Factors
Certain factors increase the risk of developing TB, including:
- Weakened immune system (e.g., HIV/AIDS, diabetes, cancer, organ transplant)
- Malnutrition
- Living in crowded or poorly ventilated conditions
- Substance abuse (alcohol or drugs)
- Close contact with someone who has active TB
- Traveling to or living in high-burden TB countries
Signs and Symptoms
The symptoms of active pulmonary TB typically develop slowly and may include:
- Persistent cough lasting more than 3 weeks (sometimes with blood-streaked sputum)
- Chest pain or discomfort
- Unexplained weight loss
- Fever and night sweats
- Fatigue and weakness
- Loss of appetite
Extrapulmonary TB symptoms depend on the organ involved. For example:
- Bone/joint TB: back pain or swelling
- Renal TB: blood in urine
- TB meningitis: severe headache, confusion, neck stiffness
Diagnosis
Early diagnosis is crucial for controlling TB. Common diagnostic methods include:
- Tuberculin Skin Test (TST) / Mantoux Test – detects prior exposure to TB bacteria.
- Interferon-Gamma Release Assays (IGRAs): blood tests for latent TB.
- Chest X-ray: shows lung involvement.
- Sputum smear microscopy: detects acid-fast bacilli.
- GeneXpert MTB/RIF test (PCR-based): rapid test to detect TB and drug resistance.
- Culture test: the gold standard but takes several weeks.
Treatment
Treatment requires strict adherence to multi-drug regimens to prevent drug resistance. The standard course is:
- First-line drugs: Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide.
- Duration: usually 6 months (2 months of intensive phase + 4 months of continuation phase).
- Directly Observed Treatment, Short-course (DOTS): ensures patients complete therapy under supervision.
Drug-Resistant TB
Improper or incomplete treatment may lead to:
- Multidrug-resistant TB (MDR-TB): resistant to isoniazid and rifampicin.
- Extensively drug-resistant TB (XDR-TB): resistant to even more drugs, making treatment very challenging.
Treatment for MDR/XDR-TB requires second-line drugs, often for 18–24 months, and can have more side effects.
Complications
Untreated or poorly managed TB can lead to severe complications such as:
- Permanent lung damage (fibrosis, cavities)
- Spread to other organs (miliary TB)
- Neurological complications (TB meningitis)
- Death in advanced cases
Prevention
Effective strategies to reduce TB spread include:
- Vaccination: Bacillus Calmette–Guérin (BCG) vaccine offers protection, especially in children against severe forms of TB.
- Infection control: isolating infectious patients, wearing masks, and improving ventilation.
- Screening and early detection: testing high-risk populations.
- Adherence to treatment: preventing drug resistance.
- Public health programs: WHO’s “End TB Strategy” aims to reduce global TB incidence and mortality.
Global Burden
According to the World Health Organization (WHO), millions of new TB cases are reported annually, with high prevalence in low- and middle-income countries. Co-infection with HIV significantly increases the risk of TB progression and mortality.
Conclusion
Tuberculosis remains a major public health challenge despite medical advances. Early diagnosis, effective treatment, patient compliance, and preventive measures are crucial to control and eventually eliminate the disease. With global efforts, proper education, and access to healthcare, the burden of TB can be significantly reduced.
